Russell Investments Group
ODT

Russell Investments Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Russell Investments Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,262
Closed -$849K – 3241
2020
Q4 		$849K Buy
44,262
+19,320
+77% +$298K ﹤0.01% 2192
2020
Q3 		$333K Buy
24,942
+15,046
+152% +$426K ﹤0.01% 2570
2020
Q2 		$418K Buy
9,896
+4,794
+94% +$155K ﹤0.01% 2445
2020
Q1 		$140K Buy
+5,102
New +$149K ﹤0.01% 2641
2019
Q3 		– Sell
-5,351
Closed -$196K – 3132
2019
Q2 		$196K Buy
5,351
+2,800
+110% +$67.1K ﹤0.01% 2516
2019
Q1 		$56K Buy
+2,551
New +$44.6K ﹤0.01% 2793

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Russell Investments Group's ODT Position: Q1 2021 in Review

Russell Investments Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2021, closing a stake of 44,262 shares — an estimated $849K sold.

Russell Investments Group first reported a position in ODT in Q1 2019 and held it in 6 quarters. The position peaked at $849K in Q4 2020. 83 funds tracked by Wall St. Rank hold ODT as of Q1 2021.

  • Russell Investments Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 44,262 Odonate Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $849K.
  • Russell Investments Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
  • Russell Investments Group's Odonate Therapeutics, Inc. Common Stock position peaked at $849K in Q4 2020.
  • 83 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.